Moderate hypofractionated radiotherapy for prostate cancer: 3-year toxicity results of a multicentre randomized phase 3, non-inferiority trial

CONCLUSION: This analysis confirms that both HFRT regimens are safe and equivalent in terms of acute grade ≥ 2 gastrointestinal toxicity.PMID:38278333 | DOI:10.1016/j.radonc.2024.110089

Source: Radiotherapy and Oncology : journal of the European Society for Therapeutic Radiology and Oncology - January 26, 2024 Category: Radiology Authors: V Fonteyne C Berghen C Van Praet B Vanderstraeten S Verbeke G Villeirs R Colman B Vanneste P Ost G De Meerleer N Lumen Source Type: research